0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Комментарии 0 Поделились 7Кб Просмотры 0 предпросмотр
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Комментарии 0 Поделились 10Кб Просмотры 0 предпросмотр
-
Endocrine Resistance–Targeting Drug Market Advances Through Breast Cancer ResearchAccording to the latest report published by Data Bridge Market Research, the Endocrine Resistance–Targeting Drug Market CAGR Value An excellent Endocrine Resistance–Targeting Drug Market research report is a great store to acquire current as well as upcoming technical and financial details and market insights of the Endocrine Resistance–Targeting Drug...0 Комментарии 0 Поделились 243 Просмотры 0 предпросмотр
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Global Cervical Cancer Therapeutics Market Future Growth ProspectsThe global cervical cancer therapeutics market size was valued at USD 6.33 billion in 2024 and is expected to grow from USD 6.61 billion in 2025 to reach USD 9.38 billion in 2033, growing at a CAGR of 4.47% during the forecast period (2025–2033). Key Highlights North America dominated the global cervical cancer therapeutics market and is expected to maintain its leading...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
How Are Treatments Advancing in Metastatic Solid Tumors Market?Executive Summary Metastatic Solid Tumors Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029. The Metastatic Solid Tumors report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast-moving business...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 Комментарии 0 Поделились 7Кб Просмотры 0 предпросмотр
-
Metastatic Melanoma Market Advances with Breakthrough Cancer TherapiesAccording to the latest report published by Data Bridge Market Research, the Metastatic Melanoma Market CAGR Value For generating the Metastatic Melanoma Market document; various steps for gathering, analysing and recording the data and information are used. When globalization is at its peak, businesses seek to take advantage of the global market for marketing and selling...0 Комментарии 0 Поделились 203 Просмотры 0 предпросмотр
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
Расширенные страницы
© 2026 Myliveroom — Live Events & Online Communities
Russian